Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 6Phase 3 3Phase 1 2Phase 2/3 1

Status

Completed 3Unknown 2Terminated 1Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 7Carcinoma, Hepatocellular 6Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Colorectal Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Rectal Neoplasms 4Recurrence 3Ovarian Neoplasms 3Multiple Myeloma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Hematologic Neoplasms 2Cholangiocarcinoma 2Biliary Tract Neoplasms 2Acute Kidney Injury 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Thymoma 1Thymic epithelial tumor 1Squamous NSCLC 1Squamous Cell Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1

Interventions

Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Neck Dissection 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Not yet recruiting × Carcinoma × Clear all
NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting
498 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡